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Background: Real-time quantitative PCR (qPCR) is a technique frequently used to measure changes in mRNA
expression. To ensure validity of experimental findings, it is important to normalize the qPCR data to reference
genes that are stable and unaffected by the experimental treatment to correct for variability among samples. Unlike
in some models of neuropathic pain, reference genes for models of inflammatory injury have not been validated.
This study examined four candidate reference genes in an effort to identify and validate optimal genes for
normalization of transcriptional changes occurring in the dorsal horn of the spinal cord and the rostral
ventromedial medulla (RVM) following intraplantar injection of complete Freund’s adjuvant (CFA).
Results: The expression of hypoxanthine phosphoribosyltransferase 1 (Hprt1), beta-actin (Actb), mitogen-activated
protein kinase 6 (Mapk6), and beta-2-microglobulin (B2m) was quantified in the dorsal horn and RVM of rats four
days or two weeks after intraplantar injection of CFA or saline. The range of expression levels among these four
genes differed by as much as 16-fold within the dorsal horn and the RVM. All four of these reference genes were
stably expressed in both tissues and did not differ between saline and CFA-treated animals. Analyses using the
statistical algorithms in geNorm and NormFinder programs determined that Mapk6 was the most stable gene and
recommended the combination of Mapk6 and Actb, or Mapk6 and Hprt1, in such experimental conditions.
Conclusions: This study validated the four genes Hprt1, Actb, Mapk6 or B2m and showed that any one or combination
of two of them are good reference genes for normalization of mRNA expression in qPCR experiments in the spinal
cord and RVM in the CFA model of inflammatory injury.
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A better understanding of the molecular changes that
occur during the development and maintenance of pain
after inflammatory injury is fundamentally important for
the development of effective therapies. Peripheral inflam-
matory injury activates signaling cascades in the peripheral
and central nervous systems as well as in the immune sys-
tem. These cascades lead to tissue swelling and increased* Correspondence: donna-hammond@uiowa.edu
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unless otherwise stated.sensitivity to both noxious and non-noxious stimuli that
can persist long after the resolution of inflammation
[1-4]. The underlying events entail transcriptional or
translational changes in numerous genes and proteins
including those involved in neurotransmitter release,
receptor function and trafficking, subcellular signaling
pathways, and regulation of ion channel expression and
activity [1-4]. Identifying the nature of these changes can
provide insights into the mechanisms of inflammatory in-
jury and may elucidate new approaches for treating in-
flammatory pain.
Changes in gene expression that occur with peripheral
inflammatory injury can be detected and measured in aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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polymerase chain reaction (qPCR) assays. Quantitative PCR
is a frequently used technique that can be easily adapted
to measure mRNA levels for any target protein and is the
method of choice for absolute or relative quantification of
mRNA expression. However, critics of qPCR maintain that
it is often inadequately standardized and frequently in-
consistent [5]. Some technical challenges inherent to the
technique include isolating high quality RNA, identifying
an efficient reverse transcriptase (RT) enzyme to generate
cDNA, designing efficient and specific primers to amplify
the desired mRNAs, and normalizing results to adequately
validated reference genes. In 2009, Bustin et al. published
the MIQE Guidelines: Minimum Information for Publica-
tion of Quantitative Real-Time PCR Experiments in an ef-
fort to standardize the information needed to ensure the
relevance, accuracy, correct interpretation, and repeatabil-
ity of qPCR experiments [6].
An essential component of qPCR is normalization of
the target mRNA to a reference gene of interest in the
same sample to control for variability associated with tem-
plate input (amount of starting material) as well as RT and
qPCR efficiencies. The reference gene mRNA should be
stably expressed, and its abundance should show a strong
correlation with the total amount of mRNA present in the
sample [6]. Control reference genes were initially termed
“housekeeping genes” because the genes were historic-
ally chosen from cellular maintenance proteins that are
ubiquitously expressed and whose mRNA was generally
thought to have uniformly unchanging expression in dif-
ferent cells and under different conditions. More recent
reports have documented that housekeeping gene expres-
sion can vary substantially (e.g. in tumor environments
and other pathophysiological states) and that the choice of
reference gene can significantly impact the conclusions of
a study [7-9]. The development of statistical algorithms
(e.g. geNorm, BestKeeper or NormFinder [10-12]) to help
researchers determine the most stable reference genes and
most appropriate combinations of reference genes has ad-
vanced the field.
Many studies of the molecular mechanisms that under-
lie the development and maintenance of pain after inflam-
matory injury have used qPCR to examine changes in
gene expression in the peripheral and central nervous
systems. Yet, to our knowledge, rigorous validation of ap-
propriate reference genes has not been undertaken. This
study quantified the expression of four potential reference
genes, hypoxanthine phosphoribosyltransferase 1 (Hprt1),
beta-actin (Actb), mitogen-activated protein kinase 6
(Mapk6), and beta-2-microglobulin (B2m), in the dorsal
horn of the spinal cord and rostral ventromedial medulla
(RVM) of the rat. These regions play important roles in
the development and maintenance of nociception after
peripheral inflammatory injury [1,4,13,14].Results
Levels of Hprt1, Actb, Mapk6, and B2m mRNA in the
dorsal horn and RVM of rats with persistent inflammatory
injury
Transcripts for Hprt1, Actb, Mapk6, and B2m were
readily detected in the dorsal horn of the spinal cord
and the RVM of rats at four days (Figure 1A,C) and two
weeks (Figure 1B,D) after intraplantar injection of saline
or CFA. The four candidate reference genes were abun-
dantly expressed in both tissues, with Cq values ranging
from 21.11 to 21.85 for Hprt1, 17.81 to 18.42 for Actb,
20.56 to 21.54 for Mapk6, and 19.07 to 19.44 for B2m.
The relative abundance of these mRNAs in both the
dorsal horn and the RVM was Actb > B2m > Mapk6 >
Hprt1 (P < 0.001).
The levels of transcripts for all four candidate refer-
ence genes in CFA-treated rats were comparable to
those in the corresponding saline-treated group in the
dorsal horn (Figure 1A,B; P > 0.5 for all genes at both
time points) and in the RVM (Figure 1C,D; P > 0.3 for
all genes at both time points). The expression of each of
the four reference genes in the dorsal horn at four days
did not differ from that at two weeks in CFA- or saline-
treated groups (P > 0.3, each gene). The expression of
B2m in the RVM also did not differ at four days and two
weeks in CFA- or saline-treated groups (P > 0.2). The ex-
pression levels of Hprt1, Actb, and MapK6 in the RVM
at four days were statistically different from correspond-
ing values at two weeks in saline- and CFA-treated rats
(P < 0.05, each gene). However, the magnitude of the dif-
ference was less than 0.2 Cq and unlikely to be biologic-
ally significant.
geNorm analysis of reference gene stability
In the geNorm program, an M value under 1.0 is indica-
tive of stable expression of mRNA [15]. In the dorsal horn,
all four genes had M values less than 0.4, demonstrating
that all four have high expression stability (Figure 2A,B).
Comparisons of pair-wise variation in the stability values
[12] of the four genes in the dorsal horn indicated that
Mapk6 and Hprt1 were the most stable transcripts at four
days and that Mapk6 and Actb were the most stable at
two weeks. When the time points were pooled in the
interest of following expression changes over time, geN-
orm analysis indicated that Actb and Mapk6 were the two
optimal genes in the dorsal horn (Figure 2C). Similarly, in
the RVM, all four genes exhibited high stability of expres-
sion at four days and two weeks after injury (Figure 2D,E).
Comparisons of pair-wise variation in the stability value
indicated that at four days Actb and Hprt1 transcripts
were the most stable, whereas at two weeks Hprt1 and
Mapk6 were the most stable (Figure 2D,E). Pooling data
for both time points indicated that Hprt1 and Mapk6 were
the two most stable genes in the RVM (Figure 2F).
Figure 1 Determination of transcript levels (Cq) of the candidate reference genes in the dorsal horn of the spinal cord (A, B) and RVM
(C, D). Levels were assessed four days (A, C) or two weeks (B, D) after intraplantar injection of CFA or saline. Values are the mean ± SEM
of determinations made in 6–7 rats. In the dorsal horn, no differences were observed in the transcripts levels between saline- and CFA-treated
rats, or between four days and two weeks, for any reference gene. In the RVM, transcript levels for each reference gene did not differ between
saline- and CFA-treated rats. Although the Cq values at two weeks were statistically different from values at four days, the magnitude of
the difference was about 0.2 Cq and unlikely to be biologically significant.
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Expression stability for the four candidate reference genes
was also calculated using NormFinder (Figure 3). In the
dorsal horn, NormFinder analysis indicated that Hprt1
and Mapk6 were the best genes for normalization at four
days and two weeks, respectively (Figure 3A,B). When the
time points were pooled, NormFinder identified Mapk6 as
the most stable gene for normalizing the expression data
in the dorsal horn (Figure 3C). In the RVM, NormFinder
analysis indicated that Actb and Hprt1 were the best genes
for normalization at four days and two weeks, respectively
(Figure 3D,E). When the data for both time points were
pooled for analysis, NormFinder identified Mapk6 as the
best gene for normalization in the RVM (Figure 3F). With
respect to the best combination of two genes to normalize
gene expression across time points, NormFinder identified
Actb and Mapk6 in both the dorsal horn and RVM.
NormFinder also includes an analysis of the optimal
number of genes for normalization. In both dorsal horn
and RVM, NormFinder identified the combination of
Mapk6, Actb, and Hprt1 as optimal. However, the addition
of one or two more genes caused at best a 0.06 decrease in
the accumulated standard deviation, much less than the
0.15 that is considered a significant change (Figure 4).
Thus, although the use of all three genes is predicted to beoptimal, one gene would be acceptable for normalization
of a target gene when resources are restricted.
Discussion
As qPCR methodology has matured and its use has be-
come more widespread, an increasing number of reports
have demonstrated that the expression of classically used
reference genes can vary substantially depending on the
experimental conditions [7-9,16]. Moreover, radically
different conclusions can be reached depending on the
reference gene used for normalization [16-19]. A PubMed
literature search (March 20, 2014; search algorithm avail-
able from authors) identified 260 papers in English that
described qPCR in rat models of nociception. The major-
ity of the papers (83%, n = 216) normalized the expression
of the target genes to a single reference gene. Glyceral-
dehyde 3-phosphate dehydrogenase (Gapdh) was used
in 48% (n = 104), Actb in 25% (n = 54), Hprt1 in 4%
(n = 8), and other housekeeping genes in the remaining
23% (n = 50) of the papers. Only 5% (n = 12) of the papers
used more than one reference gene for normalization.
When the search was restricted to studies using the CFA
model of inflammatory injury in the rat, only 16 studies
were identified. These 16 papers also normalized qPCR
data with the same reference genes and in the same
Figure 2 Assessment of reference gene stability using the geNorm algorithm. Average expression stability (M) for genes in the dorsal horn
of the spinal cord (A, B, C) and in the RVM (D, E, F), at four days (A, D) and two weeks (B,E) after intraplantar injection of CFA or saline, or for
both time points combined (C, F). All four genes were very stably expressed (M < 1.0) in both tissues and at all time points. The lowest M value
indicates the most stable gene.
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knowledge, the present study is the first to specifically val-
idate the use of reference genes for normalizing qPCR
data in the CFA model of inflammatory injury.
Optimally, the transcript of the reference gene(s) se-
lected for any given qPCR analysis will be expressed in an
abundance comparable to that of the mRNA of interest
[6]. This study identified four different reference genes –
Mapk6, Actb, Hprt1, and B2m – that can be used for the
normalization of qPCR data in the CFA model of inflam-
matory injury in rats. These four genes were selected be-
cause they are broadly expressed, involved in different
homeostatic functions (Table 1) and are not co-regulated
[12]. Moreover, two of these genes were also studied for
validation as potential reference genes in the spared nerve
injury [20] and spinal nerve ligation [21] models. The
addition of our data allows the assessment of the stability
of those genes over different pain models of chronic pain,
possibly strengthening their utility as reference genes. The
Cq values of the four genes ranged from 17 to 21.85 Cq,
reflecting a 24 or a 16-fold difference in expression. Each
gene was stably expressed within each time point: four
days (subacute injury) and two weeks (chronic injury) after
injury in CFA-treated animals compared to corresponding
saline-treated animals. Interestingly, the Cq values forthese genes in the RVM were very similar to those in the
dorsal horn. The NormFinder algorithm indicated that
Mapk6 was the reference gene with the least variability
and therefore likely the best reference gene of the four in
our experimental conditions. It also indicated that the
combined use of three reference genes (Mapk6, Actb and
Hprt1) was optimal for normalization in both the dorsal
horn and the RVM. However, the gain in stability between
the use of a single gene and the use of three genes is min-
imal, as shown by the very small changes in the accumu-
lated SD (< 0.06) between one and three genes, indicating
that any one of these three genes would be acceptable as a
unique reference gene.
The need to report qPCR data in a standardized format
is now widely accepted, and recommendations for the uni-
formity and reproducibility of qPCR experiments are listed
in the MIQE Guidelines [6]. These guidelines emphasize
the need to control for sample-to-sample variation by
normalization with reference genes. Normalization is ne-
cessary for reliable qPCR studies because the starting
material, RNA extraction, RT efficiency, and qPCR effi-
ciency can vary among experiments. Moreover, gene ex-
pression is highly tissue-specific and often varies based on
the pathophysiological status of the organism or experi-
mental treatment. Thus, it is imperative that a pilot study
Figure 3 Assessment of reference gene stability using the NormFinder analysis. Stability values for genes in the dorsal horn (A, B, C) and
in the RVM (D, E, F), at four days (A, D) and two weeks (B, E) after intraplantar injection of CFA or saline, or for both time points combined
(C, F) are shown. The lowest standard deviation (SD) indicates the most stable gene.
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optimal reference gene or combination of genes for that
specific experiment. Unfortunately, very few validation
studies for the use of reference genes exist in the pain
field, and all are restricted to nerve injury models. Several
studies have identified suitable qPCR reference genes
in dorsal root ganglia in models of neuropathic pain
[11,21,22]. For example, Mapk6 and Gapdh were identi-
fied as the two most stably expressed genes in an analysis
of L4 and L5 dorsal root ganglia following L5 spinal nerve
ligation [21]. Hprt1 and 18S were validated as stable genes
for normalizing expression levels in the dorsal root ganglia
in the spared nerve injury model [22,23], although this
conclusion was not shared by Piller et al. [20]. Seven com-
monly used reference genes, of which Actb was the most
stable, were ranked and validated as good reference genes
in spinal cord tissue in the spared nerve injury model of
neuropathic pain [20]. These reports support the conclu-
sion that the optimal reference gene(s) will be specific to
each experimental condition, and likely gender as well.
Gapdh was the single most frequently used reference
gene in the literature search but was not included in this
analysis for several reasons. Over the last decade, the
transcription of Gapdh has been reported to be signifi-
cantly regulated in different experimental settings and is
variable in different tissues [24-26]. Moreover, the rat
genome contains 329 Gapdh pseudogenes [27,28], someof which are transcribed and have the same sequence as
the active Gapdh transcript and, as such, can be detected
by primers and amplified. For example, amplification
using a published Gapdh primer pair [29]: forward (5′-
ACCACGAGAAATATGACAACTCCC) and reverse (5′-
CCAAAGTTGTCATGGATGACC), designed to amplify
a product of 100 base pairs, can give the same size
amplicon from numerous transcripts. Performing an in
silico PCR test by inserting the primer pair sequences
for Gapdh in the UCSC genome website revealed 53
PCR products, each with 100 base pairs and 18 add-
itional matches ranging from 75 to 120 base pairs, de-
rived from genes on 16 different chromosomes. Other
published primers for Gapdh yielded similar findings
[20,21]. Even if no genomic DNA contamination exists,
and the RNA samples are treated with DNase, a more op-
timal qPCR assay design is one that does not amplify any
pseudogenes. Similarly, Actb has pseudogenes [28], but
the primers used in the present study were carefully se-
lected to amplify Actb cDNA and not any of the pseudo-
gene sequences. The UCSC in silico PCR search identified
only one unique product in the rat genome with the Actb
primers used here. Hprt1 also has pseudogenes, but the
primers selected for this study are unique: one primer
spans the splice junction of the gene, and when the primer
pair is tested in silico, no genomic product was identified
since the primers can only amplify the mRNA.




Hprt1 Genbank: NM_012583 Purine synthesis in salvage pathway
Actb Genbank: NM_031144 Cytoskeletal structural protein
Mapk6 Genbank: NM_031622 Member of the Ser/Thr protein
kinase superfamily
B2m Genbank: NM_012512 Beta-chain of major histocompatibili
complex class I molecules
Figure 4 Determination of the optimal number of reference
genes by the NormFinder algorithm. Stepwise calculation of
stability began with the most stable gene (Mapk6), followed by
serial addition of the next most stable gene and calculation of the
accumulated standard deviation (circles). In both the dorsal horn
(A) and in the RVM (B), the optimal number of reference genes to
be used in qPCR experiments was three (open circle).
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In summary, this study identified four reference genes that
are stably expressed in the dorsal horn and the RVM four
days and two weeks after intraplantar injection of CFA or
saline. Each assay for the four reference genes was de-
signed with primers that were unique for their target and
would not amplify pseudogenes. Mapk6 was the most
stable reference gene, although all genes tested met the cri-
teria for a validated reference gene. We suggest that using
any one or combination of two of these assays (e.g. Mapk6
and Actb, or Mapk6 and Hprt1) for normalization of data
would yield accurate and reproducible results when study-
ing mRNA expression in the spinal cord and RVM in the
CFA model of inflammatory injury.
Methods
Animals and inflammatory injury model
Male Sprague–Dawley rats (200–350 g; Charles River,
Raleigh, NC, USA) were housed in pairs in the University
of Iowa Animal Care Facility in rooms with a 12 hr light/
dark cycle with water and food provided ad libitum. All
studies were conducted in accordance with the Guide for
Care and Use of Laboratory Animals published by the
National Institutes of Health following the guidelines
of the International Association for the Study of Pain.
The experiments were approved by the University of Iowa
Animal Care and Use Committee (protocol 1107156), and
care was taken to minimize the number of animals used
and their suffering.
Persistent inflammatory injury was induced by intra-
plantar injection of CFA. Adult rats were lightly anesthe-
tized with isoflurane, and the thickness of the hindpaw
was measured with digital calipers. The plantar surface
of the left hindpaw was injected with 150 μl of CFA
(150 μg of Mycobacterium butyricum, Calbiochem, La Jolla,
CA, USA) or sterile-filtered saline at pH 7.4. The rats were
returned to their cages and singly housed for four days or
two weeks, depending on the experiment. After the rats
were euthanized, the thickness of the hindpaw was mea-
sured to verify the presence of inflammation. Four days
after injection of CFA, the thickness of the ipsilateral hind-
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cohort was unchanged (6.2 ± 0.1 mm; N= 13; P > 0.3). Two
weeks after injection of CFA, the thickness of the ipsilat-
eral hindpaw had increased from 6.0 ± 0.1 to 9.0 ± 0.3 mm
(N = 10, P < 0.01) whereas the thickness of the hindpaw
in the saline-treated cohort was unchanged (6.0 ± 0.1 mm,
N = 10, P > 0.4). Measures of nociception were not made
to minimize stimulation.
qPCR – Quantitative Real-Time PCR Analysis
Tissue dissection
On the designated day, the rats were euthanized by CO2
inhalation and a 2-mm transverse slice of the brainstem
containing the RVM was immediately isolated on ice and
frozen on a platform on dry ice. To obtain the RVM, a
1.5-mm diameter tissue punch (Harris Unicore, Ted Pella
Inc., Redding, CA), centered on the midline immediately
above the pyramids, was removed from the frozen slice of
brainstem tissue. The remainder of the slice was fixed in
10% formalin containing 30% sucrose to allow the verifica-
tion of the site of the RVM tissue punch. The L4 and L5
portion of the spinal cord was removed, chilled on an ice-
cold platform, and the ipsilateral dorsal horn was excised.
The tissues were stored at −20°C in RNAlater™ (Ambion,
Life Technologies, Carlsbad, CA) until RNA isolation.
Primer design
DNA oligonucleotide primers were synthesized and pur-
chased from Integrated DNATechnologies (Coralville, IA).
The sequence of the forward and reverse primers for
each of the four reference genes are listed in Table 1.
The primers for Mapk6, B2m, Hprt1, and Actb are
described elsewhere [21,30,31], and checked with the
Primer 3 software (http://biotools.umassmed.edu) [32].
Each qPCR assay consists of primers that hybridize to se-
quences that lie on different exons or span a splice junc-
tion, separated by one or more introns, such that when
qPCR is conducted, only the cDNA sequence is ampli-
fied. The Ensembl database (http://useast.ensembl.org/)
was used to examine the genomic structure of the gene
and its transcripts. Special care was used in the selection
of primers for Actb and Hprt1, which are known to have
pseudogenes [12,27,28]. Contaminating genomic DNA,
if present, will not amplify any product under the re-
action conditions. Thus, only the specific mRNA tar-
gets will be measured. When the forward and reverse
primer sequences are entered into the UCSC genome bio-
informatics website (http://genome.ucsc.edu/) and tested
in silico against rat genomic DNA, only a single product is
identified for Mapk6 and Actb primers. In the case of the
Hprt1 and B2m primers, no genomic match is found be-
cause one of primers spans a splice junction and can only
hybridize with the correct cDNA sequence. In addition,
the PCR amplicons for each qPCR assay were cloned intopSC-A, the PCR cloning vector, according to the manufac-
turer’s protocol (StrataClone PCR Cloning Kit, Agilent
Technologies, Santa Clara, CA), and sequenced at the
Iowa Institute of Human Genetics, Genomics Division.
Results were aligned with the Genbank sequence for the
intended mRNA using the NCBI BLAST program to con-
firm the specificity of each primer pair. When the primers
are used in a qPCR assay, they amplify a unique species
with a sharp melting curve, and no primer-dimer products
are detected.
RNA isolation, RT, and qPCR
Total RNA was isolated from dorsal horn and RVM tissue
according to the manufacturer’s protocol (RNeasy Lipid
Tissue Mini Kit, Qiagen). Briefly, each tissue sample was
homogenized in 1 ml of QIAzol lysis reagent. The lysate
was extracted with chloroform, centrifuged, and the
supernatant saved in a clean tube. The supernatant frac-
tion was mixed with an equal volume of 70% ethanol
and loaded on the column. Samples were treated with
DNase I while on the column for 15 min at room
temperature. After washing, the RNA was eluted from
the column using RNase-free water. The concentration
of total RNA was measured on a Nanodrop spectropho-
tometer (ND1000 3.8.1, Thermo Scientific, Wilmington,
DE). The RNA integrity number was determined for 20%
of the RNA samples as further RNA quality control and
routinely showed values > 9.0 (out of 10) (Agilent Model
2100 Bioanalyzer, Santa Clara, CA). Reverse transcription
was performed according to the manufacturer’s protocol
using 100–600 ng of purified RNA and the SuperScript
VILO cDNA synthesis kit (Life Technologies, Carlsbad,
CA) in a 20 μl reaction volume. No-reverse transcript-
ase controls were also run for each RNA sample. The
qPCR was performed with each well containing the
cDNA product generated from 5 ng of input RNA, for-
ward and reverse primers (12 nM), and the fluorogenic
DNA-binding dye iQ™ SYBR® Green Supermix (Bio-Rad,
Hercules, CA) in 20 μl. Reactions were performed in
triplicate on a Bio-Rad CFX96 thermocycler (Bio-Rad,
Hercules, CA). The cycle conditions were: 50°C for
2 min, 95°C for 10 min followed by 40 cycles of (95°
C for 15 s, 60°C for 1 min and 72°C for 1 min), and
then 95°C for 1 min and 55°C for 1 min. A thermal
melting curve was generated from 55 to 95°C, at in-
crements of 0.5°C for 10 s. No reverse transcriptase
and no template controls for each primer pair were
also tested in triplicate and did not amplify any prod-
uct. Amplification efficiencies, calculated using the
Bio-Rad CFX Manager 3.0 software, were similar for all
primers and averaged at E = 101.2% ± 2.8, r2 ≥ 0.993 ±
0.002, slope = −3.30 ± 0.07. Cq values for each sample
were calculated by the Bio-Rad CFX96 software (Bio-Rad,
Hercules, CA).
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These two programs are available in the GenEX 6 soft-
ware package (http://genex.gene-quantification.info/). The
geNorm program calculates gene expression stability (M)
for each reference gene as the average of a pairwise vari-
ation for the reference gene relative to the others. The
stepwise analysis allows for a ranking of the genes accord-
ing to the calculated M value. The lower the M value, the
more stable the reference gene.
The data for NormFinder are organized in groups:
e.g. A) four day RVM, B) two week RVM, C) four day
dorsal horn, and D) two week dorsal horn. The program
calculates intra-group and inter-group variations in the
expression of the reference genes from which a stability
value is generated for each reference gene. The candidate
gene with the lowest stability value is considered the most
stable reference gene. By calculation of the standard devi-
ation of the data, the NormFinder program selects the
best number of reference genes for an experiment.
Statistical analysis
Data are expressed as mean and S.E.M. The rank order of
the expression of the four genes was analyzed by a one-
way ANOVA followed by Bonferroni’s multiple compari-
son post-hoc test. A two-way ANOVA (factors: treatment
and time) was used to compare the Cq values between
saline- and CFA-treated rats, as well as between the four
day and two week time points for each gene within each
tissue. A P ≤ 0.05 was considered significant.
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